Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer
Author(s) -
Michele Amadori,
Domenico Barone,
Emanuela Scarpi,
Devil Oboldi,
Elena Amadori,
Gianfranco Bandi,
Alice Rossi,
Fabio Ferroni,
Angela Ragazzini,
Andrea CasadeiGardini,
Giovanni Luca Frassineti,
Giampaolo Gavelli,
Alessandro Passardi
Publication year - 2018
Publication title -
european radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.606
H-Index - 149
eISSN - 1432-1084
pISSN - 0938-7994
DOI - 10.1007/s00330-017-5254-5
Subject(s) - medicine , bevacizumab , colorectal cancer , perfusion , vascularity , contrast enhanced ultrasound , interventional radiology , radiology , metastasis , ultrasound , area under the curve , neuroradiology , chemotherapy , cancer , oncology , neurology , psychiatry
To investigate early changes in tumour perfusion parameters by dynamic contrast-enhanced ultrasonography (D-CEUS) and to identify any correlation with survival and tumour response in patients with metastatic colorectal cancer (CRC) treated with bevacizumab (B).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom